Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic PBSC Transplant Without GVHD Prophylaxis in High Risk Hematologic Cancers
NCT00003396Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Sep 1998
- Primary completion
- Dec 2002
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in acute leukemia, acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), sponsored by University of Maryland, Baltimore. Started Sep 1998; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
acute leukemiaacute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00003396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003396.